Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-112-3 | CAS number: 606-28-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation, other
- Remarks:
- An in vivo eye irritation study was conducted because of negative results in the in vitro eye irritation study.
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Methyl 2-benzoylbenzoate
- EC Number:
- 210-112-3
- EC Name:
- Methyl 2-benzoylbenzoate
- Cas Number:
- 606-28-0
- Molecular formula:
- C15H12O3
- IUPAC Name:
- methyl 2-benzoylbenzoate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): RCX 14-672
- Chemical name: methyl-2-benzoylbenzoate
- Substance type: organic
- Physical state: white to light yellowish powder
- Analytical purity: >99%
- Impurities (identity and concentrations): unknown
- Lot/batch No.: N14003
- Expiration date of the lot/batch: 30 November 2015
- Stability under test conditions: stable
- Storage condition of test material: controlled room temperature (15-25°C, below 70 RH%), protected from light and humidity
Constituent 1
- Specific details on test material used for the study:
- Identification: RCX 14-672
Chemical name: methyl-2-benzoylbenzoate
Batch no.: N14003
CAS no.: 606-28-0
EC no.: 210-112-3
Molecular formula: C15H12O3
Molecular mass: 240.3 g/mol
Description: white to light yellowish powder
Purity: >99% (gas chromatography)
Water solubility: 117.7 mg/l
Test item storage: at room temperature, protected from light
Stability: stable under storage conditions
Expiry date: 30 November 2015
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- Species and strain: New Zealand White rabbits
Source: S&K-LAP Kft.
2173 Kartal, Császár út 135, Hungary
Number of animals: 3 animals
Age of animals at treatment: ~11 weeks old (adult)
Sex: Male
Body weight range
on the day of treatment: 2711 g and 2836 g
before euthanasia: 2825 g and 2900 g
Date of receipt: 27 August 2014
Acclimatization time: at least 6 days
Animal identification: The individual identification was by engraved ear tag. The cages were marked with individual identity cards with information about study code, sex, dose, cage number and individual animal number.
Light: 12 hours daily, from 6.00 a.m. to 6.00 p.m.
(and during of the analgesic/anaesthetic treatment)
Temperature
during the study: 20 ± 3°C
Relative humidity
during the study: 42 - 80 %
Housing/Enrichment: Rabbits were individually housed in AAALAC approved metal wire rabbit cages. Cages were of an open wire structure and cages were placed together to allow some social interaction with rabbit(s) in adjoining cages
Ventilation: 15-20 air exchanges/hour
The temperature and relative humidity values were measured continuously. The measured range was checked at least daily during the acclimatisation and experimental phases.
Animals received UNI diet for rabbits produced by Cargill Takarmány Zrt. (formerly Agribrands Europe Hungary), H-5300 Karcag, Madarasi út, Hungary, ad libitum.
The animals received municipal tap water, as for human consumption, ad libitum, from an automatic system. The quality control analysis is performed once every three months and microbiological assessment is performed monthly, by Veszprém County Institute of State Public Health and Medical Officer Service (ÁNTSZ, H-8201 Veszprém, József A.u.36., Hungary).
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes
- Amount / concentration applied:
- A single dose of 0.1 g of test item RCX 14-672 was administered to the animal. The test substance was placed in the conjunctival sac of the left eye of each animal after gently pulling the lower lid away from the eyeball. The lids were then gently held together for at least one second in order to prevent loss of the material. The untreated contralateral eye was served as the control.
- Duration of treatment / exposure:
- The treated eye was rinsed with physiological saline solution at the first observation time point in all animals at one hour after the application of test item as the irritation scores were greater than 1 and residual test item was noted on the eye.
- Observation period (in vivo):
- The eyes were examined at 1, 24, 48 and 72 hours after treatment.
- Number of animals or in vitro replicates:
- 3
- Details on study design:
- Identification of pH:
The pH of the test item was determined. The pH was found to be 5.5, so the test item is permitted for use in animal studies.
Pre-study examination:
Three male animals in acceptable health condition were selected for the test. Care was taken to select only those animals that had a normal eye condition and any with ocular lesions were rejected.
Chronology of animal use:
Initially only one rabbit was treated with test item. As the effect in the first rabbit was non-irritant (all scores are zero) at 24 hours, then two further rabbits were treated with test item.
Analgesic and anaesthetic treatment:
Sixty minutes (60 ±10 min) prior to test substance application, a systemic opiate analgesic was administered subcutaneous injection (SC) under direct Veterinary supervision. Five minutes (5 ±1.5 min) prior to test substance application, a topical ocular anaesthetic was applied to each eye (including the control eye to ensure direct comparison of any ocular observations). Eight hours (8 to 9 hr) after test substance application, a systemic opiate analgesic and a nonsteroidal anti-inflammatory drug (NSAID) were administered subcutaneous injection (SC) under direct Veterinary supervision. The systemic opiate analgesic was injected ~12 hours, until the ocular lesions were resolved and no clinical signs of pain or distress were present.
Systemic opiate analgesic: Buprenorphine 0.01 mg/kg.
Topical ocular anaesthetic: Humacain (oxybuprocaine) one-two drops per eye.
Nonsteroidal anti-inflammatory drug: Meloxicam 0.5 mg/kg.
Clinical Observations and Evaluation of Ocular Irritation:
The eyes were examined at 1, 24, 48 and 72 hours after treatment. The duration of the observation period was sufficient to identify reversibility or irreversibility of changes. Any clinical signs of toxicity or signs of ill-health during the study were recorded. At the end of the observation period, the animal was sacrificed by intramuscular injections of CP-Ketamin 10% and CP-Xylazin 2% followed by i.v. Pentobarbital sodium (see details in 3.2.). Death was verified by checking pupil and corneal reflex and the absence of respiration. All rabbits were examined for distress at least twice daily, with observations at least 6 hours apart. Clinical observations or signs of ill-health were recorded.
Scoring and Assessment of Local Reaction:
The eye irritation scores were evaluated according to the scoring system by Draize (1977) and OECD 405 (02 October 2012)
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Time point:
- other: 1 hour
- Score:
- 2
- Max. score:
- 2
- Reversibility:
- fully reversible within: 24 hours
- Remarks on result:
- probability of mild irritation
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Time point:
- other: 1 hour
- Score:
- 0.33
- Max. score:
- 1
- Reversibility:
- fully reversible within: 24 hours
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Time point:
- other: 1 hour
- Score:
- 0
- Max. score:
- 0
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- iris score
- Basis:
- mean
- Time point:
- other: 1 hour
- Score:
- 0
- Max. score:
- 0
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 0
- Reversibility:
- fully reversible within: 24 hours
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 0
- Reversibility:
- fully reversible within: 24 hours
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 0
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- iris score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 0
- Remarks on result:
- no indication of irritation
- Irritant / corrosive response data:
- Examination of eye-irritancy
The eyes were examined at 1, 24, 48 and 72 hours after the application. No Initial Pain Reaction (IPR/PR) was observed after application of the test item.
First animal (No: 01669) clinical observation:
At one hour after the application: Conjunctival redness (score 2), chemosis (score 1) and discharge (score 2) were found. Residual test item was noted on the eye. At 24, 48 and 72 hours after the application: There were no clinical signs, and no conjunctival or corneal effects observed. The animal was euthanized after the 72 hours observation.
Second animal (No: 01672) clinical observation:
At one hour after the application: Conjunctival redness (score 2) and discharge (score 1) were found. Residual test item was noted on the eye. At 24, 48 and 72 hours after the application: There were no clinical signs, and no conjunctival or corneal effects observed. The animal was euthanized after the 72 hours observation.
Third animal (No: 01671) clinical observation:
At one hour after the application: Conjunctival redness (score 2) and discharge (score 1) were found. Residual test item was noted on the eye. At 24, 48 and 72 hours after the application: There were no clinical signs, and no conjunctival or corneal effects observed. The animal was euthanized after the 72 hours observation. There were no clinical sign of systemic toxicity observed in the animals during the study and no mortality occurred.
During the study, the control eye of each animal was symptom-free. The body weights of the animal were considered to be within the normal range of variability.
Applicant's summary and conclusion
- Interpretation of results:
- not irritating
- Conclusions:
- The test item RCX 14-672, applied to rabbit eye mucosa, caused conjunctival effects in all animals at one hour after application. The effects were fully reversible within 24 hours.
- Executive summary:
An acute eye irritation study with RCX 14-672 was performed in New Zealand White rabbits in accordance with OECD Guideline No. 405. The irritation effects of the test item were evaluated according to the Draize method. Three male New Zealand White Rabbits were used in this study. The test item was placed into the conjunctival sac of the left eye of each animal. The untreated right eye served as control. An amount of 0.1 g of the test item was administered as a single dose. The eyes were examined at 1, 24, 48 and 72 hours after the application. No Initial Pain Reaction (IPR/PR) was observed after application of the test item. At one hour after the application: conjunctival redness (score 2), chemosis (score 1) and discharge (score 2) was observed in animal nr. 1. In the other 2 animals conjunctival redness (score 2) and discharge (score 1) were observed at one hour after the application. Residual test item was noted on the eye in all animals. At 24, 48 and 72 hours after the application, no clinical signs, and no conjunctival or corneal effects were observed in any of the animals. All animals were euthanized after the 72 hours observation. There were no clinical sign of systemic toxicity observed in the animals during the study and no mortality occurred. During the study, the control eye of each animal was symptom-free. The body weights of the animal were considered to be within the normal range of
variability.
According to Regulation (EC) No 1272/2008, RCX 14-672 does not require classification as an eye irritant. According to the UN Globally Harmonised System of Classification and Labelling of Chemicals (Rev. 5) (2013), RCX 14-672 does not require classification as an eye irritant.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.